What does APOTHEEK JANSSEN do?

APOTHEEK JANSSEN is a pharmacy in Bree. Private Limited, started on 15 May 2009, 1 establishment.

What is the address of APOTHEEK JANSSEN?

The registered office of APOTHEEK JANSSEN is located at Hoogstraat 30, 3960 Bree.

Is APOTHEEK JANSSEN still active?

Yes. According to the CBE (29 October 2026) APOTHEEK JANSSEN is active, legal situation “Normale toestand”, started on 15 May 2009.

Is APOTHEEK JANSSEN registered on Peppol?

Yes, APOTHEEK JANSSEN is registered on the Peppol network with ID 0208:0811756772.

What is the enterprise number of APOTHEEK JANSSEN?

The enterprise number of APOTHEEK JANSSEN is BE0811756772.

When was APOTHEEK JANSSEN founded?

APOTHEEK JANSSEN was founded on 15 May 2009.

Who are the directors of APOTHEEK JANSSEN?

According to the 2025 annual accounts, the directors of APOTHEEK JANSSEN are: met Apotheken BV.

Is APOTHEEK JANSSEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 May 2009; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK JANSSEN make in 2025?

APOTHEEK JANSSEN posted a profit after taxes of € 179,561 in financial year 2025.

What is the revenue of APOTHEEK JANSSEN?

As a small company, APOTHEEK JANSSEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 310,210.

How much does an employee at APOTHEEK JANSSEN earn?

The average wage cost per full-time employee at APOTHEEK JANSSEN was € 34,400 in 2023: staff costs of € 34,363 for 1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK JANSSEN have?

According to the 2025 annual accounts, APOTHEEK JANSSEN has 0.8 full-time equivalents (FTE).

Does APOTHEEK JANSSEN have a website?

Yes, APOTHEEK JANSSEN has a website at met.care.

APOTHEEK JANSSEN (Private Limited) - Bree - BE0811756772

Dossier APOTHEEK JANSSEN, printed on 29 October 2026 from databakkes.be/en/0811756772/apotheek-janssen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK JANSSEN from Bree, company number BE0811756772, closed financial year 2025 with a result of € 179,561 after tax. For that financial year APOTHEEK JANSSEN recorded a gross margin of € 310,210 and equity of € 533,512. Compared with financial year 2024, the result moved from € 154,539 to € 179,561. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2026.

What it is worth Growing

€ 533,512

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 179,561

▲ 16% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 166,138

▲ 12% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 175,000 paid out

97 % of the profit went to the shareholders, mostly to met Apotheken (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

0.8

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 35,050

▲ 67% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 5,180

▲ 124% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 13,845

▼ 52% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 41,108

▼ 32% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 17,137

▲ 58% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 212,023 Gross margin 2022: € 212,023 First fiscal year in the series	€ 254,616 Gross margin 2023: € 254,616 ▲ 20% vs 2022 (€ 212,023) Favourable step	€ 258,501 Gross margin 2024: € 258,501 ▲ 2% vs 2023 (€ 254,616) Favourable step	€ 310,210 Gross margin 2025: € 310,210 ▲ 20% vs 2024 (€ 258,501) Favourable step	▲ 20%
Profit after taxes	€ 130,437 Profit after taxes 2022: € 130,437 First fiscal year in the series	€ 151,231 Profit after taxes 2023: € 151,231 ▲ 16% vs 2022 (€ 130,437) Favourable step	€ 154,539 Profit after taxes 2024: € 154,539 ▲ 2% vs 2023 (€ 151,231) Favourable step	€ 179,561 Profit after taxes 2025: € 179,561 ▲ 16% vs 2024 (€ 154,539) Favourable step	▲ 16%
Equity	€ 498,901 Equity 2022: € 498,901 First fiscal year in the series	€ 525,632 Equity 2023: € 525,632 ▲ 5% vs 2022 (€ 498,901) Favourable step	€ 529,550 Equity 2024: € 529,550 ▲ 1% vs 2023 (€ 525,632) Favourable step	€ 533,512 Equity 2025: € 533,512 ▲ 1% vs 2024 (€ 529,550) Favourable step	▲ 1%
Total debts	€ 238,417 Total debts 2022: € 238,417 First fiscal year in the series	€ 242,643 Total debts 2023: € 242,643 ▲ 2% vs 2022 (€ 238,417) Unfavourable step	€ 252,689 Total debts 2024: € 252,689 ▲ 4% vs 2023 (€ 242,643) Unfavourable step	€ 250,187 Total debts 2025: € 250,187 ▼ 1% vs 2024 (€ 252,689) Favourable step	▼ 1%
Cash	€ 196,846 Cash 2022: € 196,846 First fiscal year in the series	€ 141,136 Cash 2023: € 141,136 ▼ 28% vs 2022 (€ 196,846) Unfavourable step	€ 148,983 Cash 2024: € 148,983 ▲ 6% vs 2023 (€ 141,136) Favourable step	€ 166,138 Cash 2025: € 166,138 ▲ 12% vs 2024 (€ 148,983) Favourable step	▲ 12%
Land & buildings	€ 172,183 Land & buildings 2022: € 172,183 First fiscal year in the series	€ 167,428 Land & buildings 2023: € 167,428 ▼ 3% vs 2022 (€ 172,183) Unchanged	€ 162,672 Land & buildings 2024: € 162,672 ▼ 3% vs 2023 (€ 167,428) Unchanged	€ 157,917 Land & buildings 2025: € 157,917 ▼ 3% vs 2024 (€ 162,672) Unchanged	▼ 3%
Retained profit	€ 438,901 Retained profit 2022: € 438,901 First fiscal year in the series	€ 465,632 Retained profit 2023: € 465,632 ▲ 6% vs 2022 (€ 438,901) Favourable step	€ 469,550 Retained profit 2024: € 469,550 ▲ 1% vs 2023 (€ 465,632) Favourable step	€ 473,512 Retained profit 2025: € 473,512 ▲ 1% vs 2024 (€ 469,550) Favourable step	▲ 1%
Dividend	€ 89,100 Dividend 2022: € 89,100 First fiscal year in the series	€ 124,500 Dividend 2023: € 124,500 ▲ 40% vs 2022 (€ 89,100) Unchanged	€ 150,000 Dividend 2024: € 150,000 ▲ 20% vs 2023 (€ 124,500) Unchanged	€ 175,000 Dividend 2025: € 175,000 ▲ 17% vs 2024 (€ 150,000) Unchanged	▲ 17%
Bank debt	€ 101,541 Bank debt 2022: € 101,541 First fiscal year in the series	€ 58,282 Bank debt 2023: € 58,282 ▼ 43% vs 2022 (€ 101,541) Favourable step	€ 28,816 Bank debt 2024: € 28,816 ▼ 51% vs 2023 (€ 58,282) Favourable step	€ 13,845 Bank debt 2025: € 13,845 ▼ 52% vs 2024 (€ 28,816) Favourable step	▼ 52%
Balance sheet total	€ 737,318 Balance sheet total 2022: € 737,318 First fiscal year in the series	€ 768,274 Balance sheet total 2023: € 768,274 ▲ 4% vs 2022 (€ 737,318) Unchanged	€ 782,239 Balance sheet total 2024: € 782,239 ▲ 2% vs 2023 (€ 768,274) Unchanged	€ 783,698 Balance sheet total 2025: € 783,698 Unchanged (€ 782,239) Unchanged
Employees (FTE)	1 Employees (FTE) 2022: 1 First fiscal year in the series	1 Employees (FTE) 2023: 1 Unchanged (1) Unchanged	0.8 Employees (FTE) 2024: 0.8 ▼ 0.2 vs 2023 (1) Unchanged	0.8 Employees (FTE) 2025: 0.8 Unchanged (0.8) Unchanged

Key figures of APOTHEEK JANSSEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK JANSSEN?

What happened at APOTHEEK JANSSEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 15, 2026 New annual accounts for financial year 2025: profit of € 179,561 (▲ 16% vs 2024). Source: NBB ↗
2022 met Apotheken BV became a director. NBB
May 15, 2009 New establishment in Bree. KBO
May 15, 2009 Start of the company according to the CBE. KBO

In short

From € 130,437 profit in 2022 to € 179,561 profit in 2025.

Paid € 161,053 in corporate taxes since 2022.

Best year ever: 2025, with € 179,561 profit.

On average € 254,600 of value added per employee in 2023.

Original PDFs at the National Bank ↗

Management

met Apotheken 100%

The stake of met Apotheken comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK JANSSEN

Behind APOTHEEK JANSSEN is met Apotheken BV. The shares are held by met Apotheken (100%).

Directors

According to the 2025 annual accounts

met Apotheken BV

Director · represented by Ben Janssen

Also active at: Apotheek Dreesen, Apotheek VAN DIJCK, Het Apothekershuis

since 2022

Shareholders

met Apotheken

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Hoogstraat 30

3960 Bree

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS met.care

About

Technologies

Alpine.jsApacheGoogle AnalyticsPHP

Hosting & Email

Email provider

Google Workspace

Hosting

GODADDY-SXB, DE

DNS

GoDaddy DNS

Domain

met.care

Registered

2022-02-09

Registrar

GoDaddy.com, LLC

Expires

2028-02-09

Website info

HTTPS Ja

Indexable pages 1

Languages NL

Features

Contact page

Security

✓ HTTPS

✓ SPF

✓ DMARC

Details

Company number: 0811.756.772
VAT number: BE 0811.756.772
Registered office: Hoogstraat 30, 3960 Bree
Names & denominations: APOTHEEK JANSSEN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 15 May 2009
Peppol: Active · Active since 30 Jun 2025
Contact: met.care [email protected] 089463260
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗